Mark Hutton is featured in Wichita Magazine's March 2008 issue as one of Wichita's Top Attorneys.
The results come from a nationwide survey of attorneys conducted by Woodward/White, Inc., a trusted research firm that publishes the Best Lawyers in America. Mark Hutton was previously chosen by his professional colleagues as one of the Best Lawyers in America 2008. Mark Hutton is best known for his practice in the fields of medical malpractice, personal injury litigation, product liability litigation and mass tort litigation. Mark Hutton considers it a privilege and an honor to be voted by his peers as one of Wichita's Top Attorneys and America's Best Lawyers.
Hutton & Hutton Seek Reimbursements For Kansans From Makers Of Vytorin ®
On January 14, 2008, the pharmaceutical giants of Merck & Co. and Schering-Plough Corp., which together manufacture, market and sell Vytorin ® , finally released the results of a study regarding how well Vytorin ® works to lower total cholesterol and reduce clogged arteries. The ENHANCE study, completed in April 2006, established that the very-expensive name-brand Vytorin ® worked no better at lowering total cholesterol than high-doses of its lower-priced generic ingredient, simvastatin, and actually accelerated placque build-up in the arteries, a major risk factor for heart disease and stroke. Read More >
Hutton & Hutton Wins $982,143 Jury Verdict
A Sedgwick County jury awarded $982,143 to the family of James “Jeff” Duncan, a 38 year old Wichita man who on February 28, 2004, went to the West Wichita Family Physicians, P.A.’s minor emergency office (“WWMEO”) complaining of significant shortness of breath on exertion. No offer of settlement was ever made by the defendant physician. Read More >
Mark and Andy Hutton Selected as 2007 Super Lawyers
For the third year in a row, Mark Hutton has been selected as one of the Top 100 Super Lawyers for Kansas and Missouri. His brother and partner, Andy Hutton, has also been selected as one of Kansas' and Missouri's 2007 Super Lawyers. Read More >
Recent News Archive >
|
|
FDA Announces Voluntary Withdrawal of Zelnorm
On March 30, 2007 the FDA notified healthcare professionals and patients that Novartis has agreed to discontinue marketing Zelnorm, a drug used for the short-term treatment of women with irritable bowel syndrome (IBS). Zelnorm is intended primarily to treat the constipation that accompanies IBS. Clinical studies showed that over 18,000 patients experienced angina, heart attacks and stroke while taking Zelnorm.
Patients taking Zelnorm should seek emergency medical care if they experience severe chest pain, shortness of breath, dizziness, sudden onset of weakness or difficulty walking or talking, or other symptoms of a heart attack or stroke. Patients should also contact their healthcare professional to discuss treatment and alternatives.
If you have taken Zelnorm you may be entitled to compensation. If you would like to explore your legal rights, please contact Hutton & Hutton to speak to an attorney.
FDA Announces Voluntary Withdrawal of Permax and Other Pergolide Drug Products
On March 29, 2007 the FDA announced that manufacturers of pergolide drug products, which are used to treat Parkinson’s disease, will voluntarily remove these drugs from the market because of the risk of serious damage to patients’ heart valves.
The products being withdrawn are Permax and two generic versions of pergolide. These drugs are used to manage the symptoms (tremors and slowness of movement) of Parkinson’s disease.
Two recent New England Journal of Medicine studies confirm previous findings associating pergolide with increased changes of regurgitation (backflow of blood) of the mitral, tricuspid and aortic valves of the heart. Valve regurgitation is a condition in which valves don’t close tightly, allowing blood to flow backward across the valve. Symptoms of valve regurgitation include shortness of breath, fatigue and heart palpitations.
Patients taking pergolide should contact their doctors to discuss alternate treatments. Patients should not stop taking the medication, as stopping pergolide abruptly can be dangerous.
If you have taken Permax or a generic version of pergolide, you may be entitled to compensation. If you would like to explore your legal rights, please contact Hutton & Hutton to speak to an attorney.
|
